Advances in chitosan-based nanoparticles for drug delivery

467Citations
Citations of this article
675Readers
Mendeley users who have this article in their library.

Abstract

Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug carriers because of some intrinsic beneficial properties including biocompatibility, biodegradability, non-toxicity, bio-activity, easy preparation, and targeting specificity. Drug transport and release from CS-based par-ticulate systems depend on the extent of cross-linking, morphology, size, and density of the partic-ulate system, as well as physicochemical properties of the drug. All these aspects have to be considered when developing new CS-based NPs as potential drug delivery systems. This comprehensive review is summarizing and discussing recent advances in CS-based NPs being developed and ex-amined for drug delivery. From this point of view, an enhancement of CS properties by its modification is presented. An enhancement in drug delivery by CS NPs is discussed in detail focusing on (i) a brief summarization of basic characteristics of CS NPs, (ii) a categorization of preparation pro-cedures used for CS NPs involving also recent improvements in production schemes of conven-tional as well as novel CS NPs, (iii) a categorization and evaluation of CS-based-nanocomposites involving their production schemes with organic polymers and inorganic material, and (iv) very recent implementations of CS NPs and nanocomposites in drug delivery.

Cite

CITATION STYLE

APA

Mikušová, V., & Mikuš, P. (2021, September 1). Advances in chitosan-based nanoparticles for drug delivery. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms22179652

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free